Europe Protein Expression Market Dynamics and Trends by 2028

The protein expression market in Europe is expected to grow from US$ 690.1 million in 2021 to US$ 1,214.6 million by 2028; it is estimated to grow at a CAGR of 8.4% from 2021 to 2028.

The pharmaceutical and biotechnology industries have developed various techniques to treat cancer and neurodegenerative diseases. The transient gene expression technique has led to significant developments in the research related to neurotrauma and neurodegenerative diseases and introduced precision medicines for these conditions. Technological advancements in epigenetics, genetics, and proteomics support the development of therapeutics for the treatment of various genetic and rare genetic diseases caused by single and multiple cell disorders. Thus, the continuous research and development activities and growing government initiatives to support precision medicine boost the adoption of protein expression techniques.

In Dec. 2020, QIAGEN has launched its QuantiFERON SARS-CoV-2 RUO solution that can detect human immune system T-cell responses to the COVID-19-causing pathogen, which may help researchers, learn more about immunity levels and disease progression. Further, the Dyadic’s proprietary C1 expressed receptor binding domain (RBD) of the SARS-CoV-2 spike protein is being used in animal trials by seven research groups, governmental agencies and biopharma companies, including the Israel Institute for Biological Research (IIBR) and a collaboration of European Union scientists participating in the ZAPI programme. However, the demand for protein expression in market in Europe during is likely to increase as the rapidly growing cases of Covid -19 and prevalence of diseases such as cancer needs research for drug development where use of protein expression is important, hence it can boost the growth of the protein expression market

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the protein expression market. The Europe protein expression market is expected to grow at a good CAGR during the forecast period.

Europe Protein Expression Market Segmentation

By Product

• Competent Cells
• Expression Vectors
• Reagents
• Instruments

By Services

• Antibody Development & Production
• Protein Expression & Production
• Hybridoma One-Stop Services
• Stable Cell Line Development
• Bioanalytical Assay Services

By Application

• Research
• Therapeutic
• Industrial

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Others

By Country

• Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Companies Mentioned

• Thermo Fisher Scientific Inc.
• GenScript
• Merck KGaA
• Agilent Technologies, Inc.
• Takara Bio Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN
• New England Biolabs
• Promega Corporation
• Oxford Expression Technologies

Europe Protein Expression Report Scope